사코페니아 치료 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 6.0%로 성장할 전망이며, 47억 2,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은, 개별화 의료, 영양 개입, 디지털 헬스 플랫폼, 환자 교육 및 임파워먼트, 세계 헬스 이니셔티브에 기인합니다. 예측 기간 주요 동향에는, 개별화 치료, 신규 약제 클래스 출현, 디지털 헬스 통합, 공동 연구 이니셔티브, 연구 개발이 포함됩니다.
예상되는 영양 실조 증가는 미래의 사코페니아 치료 시장의 성장을 가속할 것으로 예상됩니다. 영양실조는 개인의 에너지와 영양소 섭취 부족, 과잉, 불균형을 포함하며, 저영양 및 과체중, 비만, 식사와 관련된 비감염성 질환을 포함합니다. 사코페니아 치료는 근육량, 근력 및 전체적인 영양상태를 높이는 것을 목적으로 한 영양요법이나 운동 등의 개입을 통해 노인의 영양불량 및 사코페니아 병발 상태에 대처하는 데 중요한 역할을 하고 있습니다. 예를 들면, 세계보건기구(WHO)가 2023년 12월에 발표한 보고서에서는 영양 불량이 세계 건강상의 중요 과제라고 강조되고 있으며, 2022년에는 추정 4억 6,200만 명의 저체중자 및 1억 4,900만 명의 5세 미만 아동이 발육 저해를 경험한다고 했습니다. 그 결과, 영양실조의 급증이 사코페니아 치료 시장 성장의 원동력이 되고 있습니다.
사코페니아 치료 시장의 주요 기업은 치료의 선택을 늘리기 위해 여러 선진적 임상 연구를 개척하는 데 주력하고 있습니다. 임상 시험은 의료 개입의 안전성, 유효성 및 결과를 평가하기 위해 인간을 대상으로 실시되는 체계적인 조사를 포함합니다. 예를 들면, 2023년 9월, 프랑스를 거점으로 하는 바이오 테크놀로지 기업 Biophytis사는, 사코페니아를 대상으로 한 SARA-31 국면 3 시험을 개시하기 위한 식품의약국(FDA)으로부터의 인가를 공표했습니다. 본 시험은 사코네오스(BIO101)의 운동기능 장애 위험을 가진 사코페니아 환자에 대한 유효성과 안전성을 평가하는 것을 목적으로 하고 있습니다. 본 시험은 사코네오스의 기술적 및 약학적 치료법에 있어서 중요한 진보를 보여주는 것으로 중증 사코페니아 환자에 대한 유효성 및 안전성 측면에서 유익한 결과를 가져올 가능성이 있습니다. 주목할 만한 것은 FDA 승인을 받은 사코페니아 시험을 대상으로 한 첫 3상 시험이라는 것입니다. 본 시험은 사코페니아, 보행속도 저하, 악력 저하를 가진 65세 이상의 환자 약 900명을 대상으로 합니다. 주요 평가항목은 대이동장애(MMD) 리스크, 보행속도, 악력, 환자보고에 의한 QOL의 평가입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 사코페니아 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 사코페니아 치료 시장 : 성장률 분석
- 세계의 사코페니아 치료 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 사코페니아 치료 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 사코페니아 치료 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 사코페니아 치료 시장 : 치료 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 단백질 보충제
- 비타민 B12 보충제
- 비타민 D 및 칼슘 보충제
- 기타 치료 유형
- 세계의 사코페니아 치료 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 원발성 사코페니아
- 2차성 사코페니아
- 세계의 사코페니아 치료 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 오랄
- 비경구
- 경장
- 세계의 사코페니아 치료 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 약국
- 소매 약국
- 온라인 약국
- 기타 유통 채널
- 세계의 사코페니아 치료 시장 : 단백질 보충제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 유청 단백질
- 카제인 단백질
- 콩 단백질
- 식물성 단백질
- 세계의 사코페니아 치료 시장 : 비타민 B12 보충제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 시아노코발라민
- 메틸코발라민
- 세계의 사코페니아 치료 시장 : 비타민 D 및 칼슘 보충제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 비타민 D2
- 비타민 D3
- 탄산칼슘
- 구연산칼슘
- 세계의 사코페니아 치료 시장 : 기타 치료 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 운동 프로그램
- 호르몬 보충 요법
- 기타 영양 개입
제7장 지역별 및 국가별 분석
- 세계의 사코페니아 치료 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 사코페니아 치료 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 사코페니아 치료 시장 : 경쟁 구도
- 사코페니아 치료 시장 : 기업 프로파일
- Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- F-Hoffmann La-Roche 개요, 제품 및 서비스, 전략 및 재무 분석
- Merck Sharp & Dohme Corp.(Merck & Co.)개요, 제품 및 서비스, 전략 및 재무 분석
- AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Bayer AG 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Novartis AG
- Sanofi SA
- Abbott Laboratories Inc.
- GlaxoSmithKline plc
- Eli Lilly and Company
- BASF SE
- Nestle Health Science
- Haleon Group of Companies
- Regeneron Pharmaceuticals Inc.
- DSM
- American Way(Amway) Corporation
- Perrigo Company PLC
- Intas Pharmaceuticals Ltd
- Zydus Lifesciences
- Fermenta Biotech Limited
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 사코페니아 치료 시장 : 새로운 기회를 제공하는 국가(2029년)
- 사코페니아 치료 시장 : 새로운 기회를 제공하는 부문(2029년)
- 사코페니아 치료 시장 : 성장 전략(2029년)
제36장 부록
AJY
Sarcopenia treatment encompasses medical interventions and lifestyle strategies tailored to counteract age-related muscle loss, aiming to preserve or enhance skeletal muscle mass and function. The goal of treatment is to mitigate age-related muscle decline, bolster muscle strength, and improve overall physical function and mobility.
The main types of sarcopenia treatments include protein supplements, vitamin B12 supplements, vitamin D and calcium supplements, and others. Protein supplements, available in forms such as bars, powders, or shakes derived from whey, plant, or meat sources, are utilized for both primary and secondary sarcopenia treatment and can be administered orally, parenterally, or enterally. These supplements are distributed through various channels including hospital pharmacies, retail pharmacies, and online pharmacies.
The sarcopenia treatment market research report is one of a series of new reports from The Business Research Company that provides sarcopenia treatment market statistics, including sarcopenia treatment industry global market size, regional shares, competitors with a sarcopenia treatment market share, detailed sarcopenia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the sarcopenia treatment industry. This sarcopenia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sarcopenia treatment market size has grown strongly in recent years. It will grow from $3.52 billion in 2024 to $3.73 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to aging population, awareness and diagnosis, lifestyle changes, public health initiatives, regulatory approvals.
The sarcopenia treatment market size is expected to see strong growth in the next few years. It will grow to $4.72 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to personalized medicine, nutritional interventions, digital health platforms, patient education and empowerment, global health initiatives. Major trends in the forecast period include personalized therapies, emergence of novel drug classes, digital health integration, collaborative research initiatives, research and development.
The anticipated increase in malnutrition is poised to drive the growth of the sarcopenia treatment market in the future. Malnutrition encompasses deficiencies, excesses, or imbalances in an individual's intake of energy and nutrients, including both undernutrition and overweight, obesity, and diet-related noncommunicable diseases. Sarcopenia treatment plays a crucial role in addressing the concurrent conditions of malnutrition and sarcopenia in older adults through interventions such as nutritional therapy and exercise, with the aim of enhancing muscle mass, strength, and overall nutritional status. For instance, a report published by the World Health Organization (WHO) in December 2023 highlighted malnutrition as a significant global health challenge, with an estimated 462 million underweight individuals and 149 million children under 5 experiencing stunting in 2022. Consequently, the surge in malnutrition acts as a driving force behind the growth of the sarcopenia treatment market.
Major companies in the sarcopenia treatment market are intensifying their focus on developing multiple advanced clinical studies to enhance treatment options. A clinical study involves a systematic investigation conducted on human subjects to assess the safety, efficacy, and/or outcomes of a medical intervention. For instance, in September 2023, Biophytis, a France-based biotechnology company, disclosed the authorization from the Food and Drug Administration (FDA) to commence the SARA-31 Phase 3 study in sarcopenia. This study aims to assess the efficacy and safety of Sarconeos (BIO101) in treating sarcopenic patients at risk of motor disability. Representing a significant advancement in technological and pharmaceutical treatment modalities, this study offers potential benefits in terms of efficacy and safety for severe sarcopenic patients. Notably, it marks the first-ever Phase 3 study in sarcopenia to receive FDA authorization. The study will involve approximately 900 patients aged over 65 with sarcopenia, low walking speed, and low hand grip strength. The primary endpoints will include the evaluation of the risk of major mobility disability (MMD), walking speed, hand grip strength, and patient-reported quality of life.
In August 2023, Eli Lilly and Company, a pharmaceutical company based in the US, acquired Versanis Bio in a deal valued at $1.925 billion. Through this acquisition, Lilly's portfolio now includes Versanis' key asset, bimagrumab. This drug is currently in a Phase 2b clinical study, being tested both as a standalone treatment and in combination with semaglutide for adults with overweight or obesity. Versanis Bio is a biotechnology company in the US focused on developing treatments for sarcopenia.
Major companies operating in the sarcopenia treatment market report are Pfizer Inc., F-Hoffmann La-Roche, Merck Sharp & Dohme Corp. (Merck & Co.), AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Eli Lilly and Company, BASF SE, Nestle Health Science, Haleon Group of Companies, Regeneron Pharmaceuticals Inc., DSM, American Way (Amway) Corporation, Perrigo Company PLC, Intas Pharmaceuticals Ltd, Zydus Lifesciences, Fermenta Biotech Limited, Metagenics LLC, Ion Labs Inc., Makers Nutrition LLC, NutraScience Labs, AstaReal AB, NutraPak USA, BioThrive Sciences, Wellona Pharma, Healing Pharma India Pvt. Ltd., Nutrafill
North America was the largest region in the sarcopenia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the sarcopenia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sarcopenia treatment market consists of revenues earned by entities by providing nutritional therapy, combination therapy, and muscle strength. The market value includes the value of related goods sold by the service provider or included within the service offering. The sarcopenia market also includes sales of muscle stimulators, orthopedic braces and supports, joint replacement implants, anabolic agents, and more. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sarcopenia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sarcopenia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sarcopenia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sarcopenia treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment Type: Protein Supplements; Vitamin B12 Supplements; Vitamin D And Calcium Supplements; Other Treatment Types
- 2) By Type: Primary Sarcopenia; Secondary Sarcopenia
- 3) By Route Of Administration: Oral; Parenteral; Enteral
- 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
- Subsegments:
- 1) By Protein Supplements: Whey Protein; Casein Protein; Soy Protein; Plant-Based Protein
- 2) By Vitamin B12 Supplements: Cyanocobalamin; Methylcobalamin
- 3) By Vitamin D And Calcium Supplements: Vitamin D2; Vitamin D3; Calcium Carbonate; Calcium Citrate
- 4) By Other Treatment Types: Exercise Programs; Hormone Replacement Therapy; Other Nutritional Interventions
- Companies Mentioned: Pfizer Inc.; F-Hoffmann La-Roche; Merck Sharp & Dohme Corp. (Merck & Co.); AbbVie Inc.; Bayer AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Sarcopenia Treatment Market Characteristics
3. Sarcopenia Treatment Market Trends And Strategies
4. Sarcopenia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Sarcopenia Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Sarcopenia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Sarcopenia Treatment Market Growth Rate Analysis
- 5.4. Global Sarcopenia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Sarcopenia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Sarcopenia Treatment Total Addressable Market (TAM)
6. Sarcopenia Treatment Market Segmentation
- 6.1. Global Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Protein Supplements
- Vitamin B12 Supplements
- Vitamin D And Calcium Supplements
- Other Treatment Types
- 6.2. Global Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Primary Sarcopenia
- Secondary Sarcopenia
- 6.3. Global Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- Enteral
- 6.4. Global Sarcopenia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- 6.5. Global Sarcopenia Treatment Market, Sub-Segmentation Of Protein Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Whey Protein
- Casein Protein
- Soy Protein
- Plant-Based Protein
- 6.6. Global Sarcopenia Treatment Market, Sub-Segmentation Of Vitamin B12 Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cyanocobalamin
- Methylcobalamin
- 6.7. Global Sarcopenia Treatment Market, Sub-Segmentation Of Vitamin D And Calcium Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Vitamin D2
- Vitamin D3
- Calcium Carbonate
- Calcium Citrate
- 6.8. Global Sarcopenia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Exercise Programs
- Hormone Replacement Therapy
- Other Nutritional Interventions
7. Sarcopenia Treatment Market Regional And Country Analysis
- 7.1. Global Sarcopenia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Sarcopenia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Sarcopenia Treatment Market
- 8.1. Asia-Pacific Sarcopenia Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Sarcopenia Treatment Market
- 9.1. China Sarcopenia Treatment Market Overview
- 9.2. China Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Sarcopenia Treatment Market
- 10.1. India Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Sarcopenia Treatment Market
- 11.1. Japan Sarcopenia Treatment Market Overview
- 11.2. Japan Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Sarcopenia Treatment Market
- 12.1. Australia Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Sarcopenia Treatment Market
- 13.1. Indonesia Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Sarcopenia Treatment Market
- 14.1. South Korea Sarcopenia Treatment Market Overview
- 14.2. South Korea Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Sarcopenia Treatment Market
- 15.1. Western Europe Sarcopenia Treatment Market Overview
- 15.2. Western Europe Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Sarcopenia Treatment Market
- 16.1. UK Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Sarcopenia Treatment Market
- 17.1. Germany Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Sarcopenia Treatment Market
- 18.1. France Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Sarcopenia Treatment Market
- 19.1. Italy Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Sarcopenia Treatment Market
- 20.1. Spain Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Sarcopenia Treatment Market
- 21.1. Eastern Europe Sarcopenia Treatment Market Overview
- 21.2. Eastern Europe Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Sarcopenia Treatment Market
- 22.1. Russia Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Sarcopenia Treatment Market
- 23.1. North America Sarcopenia Treatment Market Overview
- 23.2. North America Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Sarcopenia Treatment Market
- 24.1. USA Sarcopenia Treatment Market Overview
- 24.2. USA Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Sarcopenia Treatment Market
- 25.1. Canada Sarcopenia Treatment Market Overview
- 25.2. Canada Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Sarcopenia Treatment Market
- 26.1. South America Sarcopenia Treatment Market Overview
- 26.2. South America Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Sarcopenia Treatment Market
- 27.1. Brazil Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Sarcopenia Treatment Market
- 28.1. Middle East Sarcopenia Treatment Market Overview
- 28.2. Middle East Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Sarcopenia Treatment Market
- 29.1. Africa Sarcopenia Treatment Market Overview
- 29.2. Africa Sarcopenia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Sarcopenia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Sarcopenia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Sarcopenia Treatment Market Competitive Landscape And Company Profiles
- 30.1. Sarcopenia Treatment Market Competitive Landscape
- 30.2. Sarcopenia Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F-Hoffmann La-Roche Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck Sharp & Dohme Corp. (Merck & Co.) Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
31. Sarcopenia Treatment Market Other Major And Innovative Companies
- 31.1. Novartis AG
- 31.2. Sanofi S.A.
- 31.3. Abbott Laboratories Inc.
- 31.4. GlaxoSmithKline plc
- 31.5. Eli Lilly and Company
- 31.6. BASF SE
- 31.7. Nestle Health Science
- 31.8. Haleon Group of Companies
- 31.9. Regeneron Pharmaceuticals Inc.
- 31.10. DSM
- 31.11. American Way (Amway) Corporation
- 31.12. Perrigo Company PLC
- 31.13. Intas Pharmaceuticals Ltd
- 31.14. Zydus Lifesciences
- 31.15. Fermenta Biotech Limited
32. Global Sarcopenia Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Sarcopenia Treatment Market
34. Recent Developments In The Sarcopenia Treatment Market
35. Sarcopenia Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Sarcopenia Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Sarcopenia Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Sarcopenia Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
